Jonathan Benjamin, M.D., Ph.D

Jonathan Benjamin is a hematologist, oncologist, and immunologist. Prior to joining ImmPACT in September 2022 as CMO, Dr. Benjamin was Senior Vice President for Clinical Research at Atreca where he directed sample acquisition efforts to support drug discovery, built the clinical development organization, and led development of its first clinical-stage asset. Previously, he was Medical Director at Amgen to work on the development and global registration of the bispecific T-cell engager (BiTE®) Blincyto® for B-cell Acute Lymphoblastic Leukemia. Before entering the biotechnology industry, he was assistant professor and attending physician in the Division of Blood and Marrow Transplantation at Stanford University.

Dr. Benjamin received his bachelor degree from Harvard College and M.D and Ph.D degrees from New York University. He completed his postgraduate training at the University of California San Francisco.